The melanoma clinical will be only a proof of concept, so it won't be necessary to have a large sample size for each PD-1(L) inhibitor.
So I guess each one that has shown promise in the preclinical will be included in the clinical.
The target audience is BP, not the FDA.
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-439
-
-
- There are more pages in this discussion • 1,375 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
HCH
Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.89 |
Change
0.120(6.80%) |
Mkt cap ! $321.0M |
Open | High | Low | Value | Volume |
$1.78 | $1.93 | $1.78 | $563.4K | 302.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 108 | $1.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.90 | 4926 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 108 | 1.880 |
2 | 8000 | 1.855 |
4 | 12250 | 1.850 |
2 | 32500 | 1.840 |
1 | 2500 | 1.835 |
Price($) | Vol. | No. |
---|---|---|
1.900 | 4926 | 1 |
1.920 | 2311 | 1 |
1.930 | 275 | 1 |
1.935 | 10400 | 1 |
1.940 | 5260 | 1 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |